You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pomalidomide

Showing 201 - 225 of 253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Dexamethasone, Lenalidomide, Pomalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic
Aug 14, 2018

Multiple Myeloma Trial in New York (Romidepsin, pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
May 31, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

Multiple Myeloma, Relapse After Use of Lenalidomide and Bortezomib Trial in Singapore (Pomalidomide and Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Relapse After Use of Lenalidomide and Bortezomib
  • Pomalidomide and Dexamethasone
  • Singapore, Singapore
  • +1 more
May 13, 2018

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its

Recruiting
  • Multiple Myeloma
    • Torino, TO, Italy
      Aou Citta' Della Salute E Della Scienza Di Torino
    Aug 17, 2021

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Primary Amyloidosis of Light Chain Type Trial in Pavia (Pomalidomide and Dexamethasone)

    Completed
    • Primary Amyloidosis of Light Chain Type
    • Pomalidomide and Dexamethasone
    • Pavia, Italy
      Centro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fon
    Mar 8, 2018

    Bioequivalence Trial in Taiyuan (Pomalidomide 4 MG Oral Capsule, Pomalidomide 4 MG Oral Capsule-Pomalyst)

    Completed
    • Bioequivalence
    • Pomalidomide 4 MG Oral Capsule
    • Pomalidomide 4 MG Oral Capsule-Pomalyst
    • Taiyuan, Shanxi, China
      The second hospital of shanxi medical university
    Feb 6, 2018

    Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Barcelona, Spain
    • +15 more
    Feb 15, 2021

    Multiple Myeloma Trial in France (Isatuximab, ASCT)

    Recruiting
    • Multiple Myeloma
    • AMIENS Cedex 1, France
    • +67 more
    Mar 28, 2022

    Multiple Myeloma Trial in Worldwide (pomalidomide, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Rochester, Minnesota
    • +93 more
    Sep 25, 2018

    Multiple Myeloma, Tumors, Plasma Cells Trial (Lenalidomide)

    Withdrawn
    • Multiple Myeloma
    • +6 more
    • (no location specified)
    Apr 9, 2018

    Multiple Myeloma Trial in Spain (Nivolumab, Pomalidomide, Dexamethasone)

    Terminated
    • Multiple Myeloma
    • Badalona, Spain
    • +11 more
    May 22, 2018

    Relapsed or Refractory Multiple Myeloma Trial in Tuebingen (Imnovid (pomalidomide), Dexamethasone, Endoxan (Cyclophosphamide))

    Completed
    • Relapsed or Refractory Multiple Myeloma
    • Imnovid (pomalidomide)
    • +2 more
    • Tuebingen, Germany
      University Hospital
    Oct 27, 2017

    Non-Hodgkin's Lymphoma (NHL), Multiple Myeloma, Waldenstrom's Macroglobulinemia (WM) Trial in United States (CB-839, CB-839 and

    Completed
    • Non-Hodgkin's Lymphoma (NHL)
    • +4 more
    • Scottsdale, Arizona
    • +6 more
    Jul 16, 2018

    Advanced Multiple Myeloma Trial in Worldwide (Filanesib, KSP (Eg5) inhibitor; intravenous, Filgrastim, granulocyte-colony

    Completed
    • Advanced Multiple Myeloma
    • Filanesib, KSP (Eg5) inhibitor; intravenous
    • Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
    • Birmingham, Alabama
    • +59 more
    Oct 13, 2020

    Incidence of Cereblon in Intensive Care Patients

    Not yet recruiting
    • Critical Illness
    • Sepsis
      • (no location specified)
      Oct 6, 2021

      Multiple Myeloma Trial in Chicago (Screening Phase, Discontinuation Phase)

      Recruiting
      • Multiple Myeloma
      • Screening Phase
      • Discontinuation Phase
      • Chicago, Illinois
        University Of Chicago Medicine Comprehensive Cancer Center
      Jan 8, 2021

      Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Jacksonville, Rochester (dexamethasone, pomalidomide)

      Completed
      Has Results
      • Multiple Myeloma and Plasma Cell Neoplasm
      • Scottsdale, Arizona
      • +2 more
      Mar 20, 2018

      Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Multiple Myeloma Trial in Australia, United States (pomalidomide,

      Completed
      • Multiple Myeloma in Relapse
      • +2 more
      • pomalidomide
      • +2 more
      • Chicago, Illinois
      • +5 more
      Nov 20, 2017

      Polycythemia Vera Trial in Worldwide (ruxolitinib tablets, Best Available Therapy (BAT))

      Completed
      Has Results
      • Polycythemia Vera
      • ruxolitinib tablets
      • Best Available Therapy (BAT)
      • Birmingham, Alabama
      • +101 more
      Feb 8, 2019

      Myeloproliferative Tumors Trial in Germany (Pomalidomide)

      Completed
      • Myeloproliferative Neoplasms
      • Pomalidomide
      • Aachen, Germany
      • +14 more
      Sep 21, 2017

      Multiple Myeloma Trial in Worldwide (ABBV-838, Pomalidomide, Dexamethasone)

      Terminated
      • Multiple Myeloma
      • Chicago, Illinois
      • +18 more
      Sep 12, 2018

      Multiple Myeloma Trial in Paris (Daratumumab)

      Withdrawn
      • Multiple Myeloma
      • Paris, France
        Service d'hématologie clinique et thérapie cellulaire
      Mar 25, 2020